A 7-year-old boy was brought for evaluation of a rash on the chin that had appeared 2 weeks earlier. It was slightly itchy. The mother had applied a topical corticosteroid for a few days but then stopped because of worsening of the lesion.
A 7-year-old boy was brought for evaluation of a rash on the chin that had appeared 2 weeks earlier. It was slightly itchy. The mother had applied a topical corticosteroid for a few days but then stopped because of worsening of the lesion.
The erythematous, scaly lesion with a well-defined border on this boy's face is characteristic of tinea faciei. As the lesion spreads peripherally, the center often clears and produces the classic annular lesion that is responsible for the designation of ringworm. Microscopic examination of a potassium hydroxide preparation of scrapings from the lesion showed numerous septate hyphae. This confirmed a dermatophyte infection; culture can also establish the diagnosis. Scrapings from scales at the edge of the lesion produce the best results.
Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, and Microsporum canis are the most prevalent causative organisms.1 Rarely, tinea faciei can be caused by Microsporum gypseum.2 Occasionally, tinea faciei may simulate polymorphous light eruption, seborrheic dermatitis, contact dermatitis, impetigo, discoid lupus erythematosus, and acne rosacea.2,3
Tinea faciei usually responds to application of a topical antifungal agent, such as micronazole, ketoconazole, econazole, naftifine, or terbinafine. In difficult-to-treat cases, oral itraconazole or fluconazole can be considered. This child was treated with topical terbinafine. The lesion resolved within 10 days.
REFERENCES:
1. Leung AKC, Robson WLM. Tinea faciei. Can J CME. 2006;18(10):73.
2. Criado PR, Costa AR, Vasconcellos C, et al. Tinea faciei in an infant caused by Microsporum gypseum simulating a dry impetigo. Pediatr Dermatol. 2005;22:536-538.
3. Gorani A, Oriani A, Cambiaghi S. Seborrheic dermatitis-like tinea faciei. Pediatr Dermatol. 2005;22:243-244.
Lawrence Eichenfield, MD, talks tapinarof cream, 1%, nemolizumab FDA approvals for atopic dermatitis
December 20th 2024"Tapinarof comes in with that mixture of the short-term studies and longer-term studies intermittently, giving us a nice, effective alternative non-steroid for eczema across the ages."
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.